Literature DB >> 32350082

Distinct Features of Human Myeloid Cell Cytokine Response Profiles Identify Neutrophil Activation by Cytokines as a Prognostic Feature during Tuberculosis and Cancer.

Joseph C Devlin1,2,3, Erin E Zwack2, Mei San Tang2, Zhi Li3, David Fenyo3,4, Victor J Torres5, Kelly V Ruggles6,3,7,8, P'ng Loke5,9.   

Abstract

Myeloid cells are a vital component of innate immunity and comprise monocytes, macrophages, dendritic cells, and granulocytes. How myeloid cell lineage affects activation states in response to cytokines remains poorly understood. The cytokine environment and cellular infiltrate during an inflammatory response may contain prognostic features that predict disease outcome. In this study, we analyzed the transcriptional responses of human monocytes, macrophages, dendritic cells, and neutrophils in response to stimulation by IFN-γ, IFN-β, IFN-λ, IL-4, IL-13, and IL-10 cytokines to better understand the heterogeneity of activation states in inflammatory conditions. This generated a myeloid cell-cytokine-specific response matrix that can infer representation of myeloid cells and the cytokine environment they encounter during infection, in tumors and in whole blood. Neutrophils were highly responsive to type 1 and type 2 cytokine stimulation but did not respond to IL-10. We identified transcripts specific to IFN-β stimulation, whereas other IFN signature genes were upregulated by both IFN-γ and IFN-β. When we used our matrix to deconvolute blood profiles from tuberculosis patients, the IFN-β-specific neutrophil signature was reduced in tuberculosis patients with active disease, whereas the shared response to IFN-γ and IFN-β in neutrophils was increased. When applied to glioma patients, transcripts of neutrophils exposed to IL-4/IL-13 and monocyte responses to IFN-γ or IFN-β emerged as opposing predictors of patient survival. Hence, by dissecting how different myeloid cells respond to cytokine activation, we can delineate biological roles for myeloid cells in different cytokine environments during disease processes, especially during infection and tumor progression.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32350082      PMCID: PMC7276940          DOI: 10.4049/jimmunol.1901133

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  A meta-analysis of lung cancer gene expression identifies PTK7 as a survival gene in lung adenocarcinoma.

Authors:  Ron Chen; Purvesh Khatri; Pawel K Mazur; Melanie Polin; Yanyan Zheng; Dedeepya Vaka; Chuong D Hoang; Joseph Shrager; Yue Xu; Silvestre Vicent; Atul J Butte; E Alejandro Sweet-Cordero
Journal:  Cancer Res       Date:  2014-03-20       Impact factor: 12.701

2.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

3.  Standardized whole blood stimulation improves immunomonitoring of induced immune responses in multi-center study.

Authors:  Darragh Duffy; Vincent Rouilly; Cecile Braudeau; Véronique Corbière; Raouf Djebali; Marie-Noelle Ungeheuer; Regis Josien; Samuel T LaBrie; Olivier Lantz; Delphine Louis; Eva Martinez-Caceres; Francoise Mascart; Jose G Ruiz de Morales; Catherine Ottone; Lydia Redjah; Nina Salabert-Le Guen; Alain Savenay; Manfred Schmolz; Antoine Toubert; Matthew L Albert
Journal:  Clin Immunol       Date:  2017-09-22       Impact factor: 3.969

4.  Parsing the Interferon Transcriptional Network and Its Disease Associations.

Authors:  Sara Mostafavi; Hideyuki Yoshida; Devapregasan Moodley; Hugo LeBoité; Katherine Rothamel; Towfique Raj; Chun Jimmie Ye; Nicolas Chevrier; Shen-Ying Zhang; Ting Feng; Mark Lee; Jean-Laurent Casanova; James D Clark; Martin Hegen; Jean-Baptiste Telliez; Nir Hacohen; Philip L De Jager; Aviv Regev; Diane Mathis; Christophe Benoist
Journal:  Cell       Date:  2016-01-28       Impact factor: 41.582

5.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

6.  Integrated, Multi-cohort Analysis Identifies Conserved Transcriptional Signatures across Multiple Respiratory Viruses.

Authors:  Marta Andres-Terre; Helen M McGuire; Yannick Pouliot; Erika Bongen; Timothy E Sweeney; Cristina M Tato; Purvesh Khatri
Journal:  Immunity       Date:  2015-12-15       Impact factor: 31.745

Review 7.  Neutrophils in Gliomas.

Authors:  Matteo Massara; Pasquale Persico; Ornella Bonavita; Valeria Mollica Poeta; Massimo Locati; Matteo Simonelli; Raffaella Bonecchi
Journal:  Front Immunol       Date:  2017-10-26       Impact factor: 7.561

Review 8.  IDH1 and IDH2 mutations in gliomas.

Authors:  Adam L Cohen; Sheri L Holmen; Howard Colman
Journal:  Curr Neurol Neurosci Rep       Date:  2013-05       Impact factor: 6.030

9.  Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study.

Authors:  Myrsini Kaforou; Victoria J Wright; Tolu Oni; Neil French; Suzanne T Anderson; Nonzwakazi Bangani; Claire M Banwell; Andrew J Brent; Amelia C Crampin; Hazel M Dockrell; Brian Eley; Robert S Heyderman; Martin L Hibberd; Florian Kern; Paul R Langford; Ling Ling; Marc Mendelson; Tom H Ottenhoff; Femia Zgambo; Robert J Wilkinson; Lachlan J Coin; Michael Levin
Journal:  PLoS Med       Date:  2013-10-22       Impact factor: 11.069

10.  Proteogenomics connects somatic mutations to signalling in breast cancer.

Authors:  Philipp Mertins; D R Mani; Kelly V Ruggles; Michael A Gillette; Karl R Clauser; Pei Wang; Xianlong Wang; Jana W Qiao; Song Cao; Francesca Petralia; Emily Kawaler; Filip Mundt; Karsten Krug; Zhidong Tu; Jonathan T Lei; Michael L Gatza; Matthew Wilkerson; Charles M Perou; Venkata Yellapantula; Kuan-lin Huang; Chenwei Lin; Michael D McLellan; Ping Yan; Sherri R Davies; R Reid Townsend; Steven J Skates; Jing Wang; Bing Zhang; Christopher R Kinsinger; Mehdi Mesri; Henry Rodriguez; Li Ding; Amanda G Paulovich; David Fenyö; Matthew J Ellis; Steven A Carr
Journal:  Nature       Date:  2016-05-25       Impact factor: 49.962

View more
  2 in total

1.  Engineering chimeric antigen receptor neutrophils from human pluripotent stem cells for targeted cancer immunotherapy.

Authors:  Yun Chang; Ramizah Syahirah; Xuepeng Wang; Gyuhyung Jin; Sandra Torregrosa-Allen; Bennett D Elzey; Sydney N Hummel; Tianqi Wang; Can Li; Xiaojun Lian; Qing Deng; Hal E Broxmeyer; Xiaoping Bao
Journal:  Cell Rep       Date:  2022-07-19       Impact factor: 9.995

2.  Innate Immune Training of Granulopoiesis Promotes Anti-tumor Activity.

Authors:  Lydia Kalafati; Ioannis Kourtzelis; Jonas Schulte-Schrepping; Xiaofei Li; Aikaterini Hatzioannou; Tatyana Grinenko; Eman Hagag; Anupam Sinha; Canan Has; Sevina Dietz; Antonio Miguel de Jesus Domingues; Marina Nati; Sundary Sormendi; Ales Neuwirth; Antonios Chatzigeorgiou; Athanasios Ziogas; Mathias Lesche; Andreas Dahl; Ian Henry; Pallavi Subramanian; Ben Wielockx; Peter Murray; Peter Mirtschink; Kyoung-Jin Chung; Joachim L Schultze; Mihai G Netea; George Hajishengallis; Panayotis Verginis; Ioannis Mitroulis; Triantafyllos Chavakis
Journal:  Cell       Date:  2020-10-29       Impact factor: 41.582

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.